Switch to:
Valeant Pharmaceuticals International Inc  (NYSE:VRX) Gross Margin %: 71.07% (As of Jun. 2017)

Gross Margin % is calculated as gross profit divided by its revenue. Valeant Pharmaceuticals International Inc's Gross Profit for the three months ended in Jun. 2017 was $1,587 Mil. Valeant Pharmaceuticals International Inc's Revenue for the three months ended in Jun. 2017 was $2,233 Mil. Therefore, Valeant Pharmaceuticals International Inc's Gross Margin % for the quarter that ended in Jun. 2017 was 71.07%.


NYSE:VRX' s Gross Margin % Range Over the Past 10 Years
Min: 65.65   Max: 75.26
Current: 72.18

65.65
75.26

During the past 13 years, the highest Gross Margin % of Valeant Pharmaceuticals International Inc was 75.26%. The lowest was 65.65%. And the median was 72.88%.

NYSE:VRX's Gross Margin % is ranked higher than
84% of the 746 Companies
in the Global industry.

( Industry Median: 49.32 vs. NYSE:VRX: 72.18 )

Valeant Pharmaceuticals International Inc had a gross margin of 71.07% for the quarter that ended in Jun. 2017 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Valeant Pharmaceuticals International Inc was 0.90% per year.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Valeant Pharmaceuticals International Inc Annual Data

Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Gross Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 72.14 66.98 72.75 75.26 73.01

Valeant Pharmaceuticals International Inc Quarterly Data

Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
Gross Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 72.81 73.46 72.31 71.74 71.07

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Valeant Pharmaceuticals International Inc's Gross Margin for the fiscal year that ended in Dec. 2016 is calculated as

Gross Margin % (A: Dec. 2016 )=Gross Profit (A: Dec. 2016 ) / Revenue (A: Dec. 2016 )
=7063 / 9674
=(Revenue - Cost of Goods Sold) / Revenue
=(9674 - 2611) / 9674
=73.01 %

Valeant Pharmaceuticals International Inc's Gross Margin for the quarter that ended in Jun. 2017 is calculated as


Gross Margin % (Q: Jun. 2017 )=Gross Profit (Q: Jun. 2017 ) / Revenue (Q: Jun. 2017 )
=-646 / 2233
=(Revenue - Cost of Goods Sold) / Revenue
=(2233 - 646) / 2233
=71.07 %

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Valeant Pharmaceuticals International Inc had a gross margin of 71.07% for the quarter that ended in Jun. 2017 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Related Terms


Headlines

From the Internet

VRX
Allergan Pharma Darling Faces Uncertainty

- Seekingalpha 2017-10-18 03:36:31

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK